OnKure Therapeutics, Inc.
OKUR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001637715
In the last 90 days, OnKure Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 75 institutions reported holding it in 13F filings for Q2 2026, worth $159.0M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in OnKure Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +4 vs. Q4 2022
- Shares held
- 17.1M
- +2.68M (+18.6%) vs. Q4 2022
- Total value
- $102.0M
- +$68.4M (+203.8%) vs. Q4 2022
- New holders
- 7
- 9 more added
- Sold out
- 3
- 7 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OKUR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 75 | $159.0M |
| Q1 2026 | 51 | $113.9M |
| Q4 2025 | 44 | $32.0M |
| Q3 2025 | 42 | $28.1M |
| Q2 2025 | 49 | $25.8M |
| Q1 2025 | 47 | $50.1M |
| Q4 2024 | 51 | $99.2M |
| Q3 2024 | 51 | $49.0M |
| Q2 2024 | 66 | $41.3M |
| Q1 2024 | 62 | $45.4M |
| Q4 2023 | 68 | $40.4M |
| Q3 2023 | 58 | $208.3M |
| Q2 2023 | 52 | $168.9M |
| Q1 2023 | 35 | $102.0M |
| Q4 2022 | 32 | $38.4M |
| Q3 2022 | 33 | $55.1M |
| Q2 2022 | 33 | $43.3M |
| Q1 2022 | 41 | $50.8M |
| Q4 2021 | 39 | $148.9M |
| Q3 2021 | 38 | $136.7M |
| Q2 2021 | 38 | $170.6M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding OnKure Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 4,785,494 | $28.6M | 1.98% | 00.0% | Unchanged |
| Novo Holdings A/S | 3,430,377 | $20.5M | 1.46% | 00.0% | Unchanged |
| RiverVest Venture Management LLC | 2,409,220 | $14.4M | 16.67% | 00.0% | Unchanged |
| Carlyle Group Inc. | 2,073,957 | $12.2M | 0.37% | +2,073,957 | New |
| Rock Springs Capital Management LP | 1,143,185 | $6.84M | 0.16% | 00.0% | Unchanged |
| Aisling Capital Management LP | 886,075 | $5.30M | 2.55% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 420,000 | $2.51M | 0.36% | +420,000 | New |
| Franklin Resources Inc | 407,605 | $2.44M | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 317,982 | $1.90M | 0.00% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 245,787 | $1.47M | 0.02% | +107,135+77.3% | Added |
| Ikarian Capital, LLC | 155,819 | $931.8K | 0.39% | 00.0% | Unchanged |
| Great Point Partners LLC | 120,864 | $722.8K | 0.14% | +120,864 | New |
| Geode Capital Management, LLC | 96,611 | $577.7K | 0.00% | +8,297+9.4% | Added |
| Federated Hermes, Inc. | 78,390 | $468.8K | 0.00% | −1,610−2.0% | Reduced |
| Barclays PLC | 71,930 | $430.1K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 53,428 | $319.5K | 0.01% | +26,196+96.2% | Added |
| UBS Group AG | 52,961 | $316.7K | 0.00% | −4,586−8.0% | Reduced |
| Morgan Stanley | 42,329 | $253.1K | 0.00% | +2,760+7.0% | Added |
| Dimensional Fund Advisors LP | 37,024 | $221.4K | 0.00% | +17,472+89.4% | Added |
| Susquehanna International Group, LLP | 32,358 | $193.5K | 0.00% | +32,358 | New |
| Renaissance Technologies LLC | 25,600 | $153.0K | 0.00% | −11,600−31.2% | Reduced |
| Bridgeway Capital Management, LLC | 25,000 | $149.5K | 0.00% | −45,000−64.3% | Reduced |
| Millennium Management LLC | 23,935 | $143.0K | 0.00% | −9,124−27.6% | Reduced |
| BlackRock Inc. | 23,637 | $141.3K | 0.00% | −666−2.7% | Reduced |
| Commonwealth Equity Services, LLC | 22,347 | $133.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 19,743 | $118.1K | 0.00% | +19,743 | New |
| JPMorgan Chase & Co | 19,776 | $118.0K | 0.00% | +310+1.6% | Added |
| State Street Corp | 16,400 | $98.1K | 0.00% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 15,967 | $95.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,032 | $89.9K | 0.00% | +3,125+26.2% | Added |
| Prelude Capital Management, LLC | 14,800 | $88.5K | 0.01% | +14,800 | New |
| Tower Research Capital LLC (TRC) | 2,476 | $15.0K | 0.00% | −3,442−58.2% | Reduced |
| Wells Fargo & Company | 1,264 | $7.56K | 0.00% | +1+0.1% | Added |
| Bank of America Corp | 865 | $5.17K | 0.00% | +288+49.9% | Added |
| Global Retirement Partners, LLC | 100 | $987 | 0.00% | +100 | New |
| Bank of Montreal | 0 | $0 | 0.00% | −33,500−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −30,587−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −30,251−100.0% | Sold out |
| Abingworth LLP | – | – | – | – | Not filed |